Ernexa Therapeutics Inc. (ERNA)

NCM – Real Time Price. Currency in USD

4.38

-0.06 (-1.35%)

Market open: Aug 12, 2026, 11:45 AM EDT

4.36

-0.03 (-0.68%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

10.08.2026

Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage

Seasoned biotechnology founder, public company CFO and corporate strategist brings more than 25 years of leadership in oncology, capital markets, M&A and corporate governance

Videos

No Data

There is no data to display

Press releases

10.08.2026

Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage

Seasoned biotechnology founder, public company CFO and corporate strategist brings more than 25 years of leadership in oncology, capital markets, M&A and corporate governance

Ernexa Therapeutics Inc. (ERNA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ernexa Therapeutics Inc. (ERNA)

Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage

Videos

No Data

Press releases

Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage

Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage

Videos

No Data

Press releases

Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage

Search stocks

Ernexa Therapeutics Inc. (ERNA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ernexa Therapeutics Inc. (ERNA)

Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage

Videos

No Data

Press releases

Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage

Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage

Videos

No Data

Press releases

Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage